More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effects
- 1 February 2006
- Vol. 67 (2) , 343-348
- https://doi.org/10.1016/j.urology.2005.08.048
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Prostate cancer trends in the era of prostate-specific antigenUrologic Clinics of North America, 2002
- ERA SPECIFIC BIOCHEMICAL RECURRENCE-FREE SURVIVAL FOLLOWING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 2001
- Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer?JAMA, 2000
- POTENCY, CONTINENCE AND COMPLICATION RATES IN 1,870 CONSECUTIVE RADICAL RETROPUBIC PROSTATECTOMIESJournal of Urology, 1999
- THE COMBINATION OF PREOPERATIVE PROSTATE SPECIFIC ANTIGEN AND POSTOPERATIVE PATHOLOGICAL FINDINGS TO PREDICT PROSTATE SPECIFIC ANTIGEN OUTCOME IN CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 1998
- CANCER RECURRENCE AND SURVIVAL RATES AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY FOR PROSTATE CANCERJournal of Urology, 1998
- ANATOMIC RADICAL PROSTATECTOMYJournal of Urology, 1998
- Influence of Prostate-Specific Antigen Testing on the Spectrum of Patients With Prostate Cancer Undergoing Radical Prostatectomy at a Large Referral PracticeMayo Clinic Proceedings, 1998
- Radical prostatectomy for adenocarcinoma of the prostate: The influence of preoperative and pathologic findings on biochemical disease-free outcomeUrology, 1994
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991